financetom
Business
financetom
/
Business
/
UK antitrust watchdog says SLB-ChampionX deal could lessen competition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK antitrust watchdog says SLB-ChampionX deal could lessen competition
Mar 27, 2025 4:38 AM

March 27 (Reuters) - Britain's competition regulator

said on Thursday that oilfield services company SLB's

proposed $8 billion deal to buy smaller rival ChampionX ( CHX )

could result in a substantial lessening of competition within

the UK.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fastly Plans Cut to Global Workforce by 11% to Reduce Expenses
Fastly Plans Cut to Global Workforce by 11% to Reduce Expenses
Aug 9, 2024
03:35 PM EDT, 08/09/2024 (MT Newswires) -- Fastly (FSLY) said in a filing Thursday that it will cut its global workforce by about 11% as part of a restructuring plan to reduce expenses. The restructuring will cost an estimated $9.5 million to $10 million in Q3, primarily covering cash expenditures for severance payments, employee benefits, and related charges for layoffs,...
Piper Sandler Raises Canopy Growth Sales Estimates For FY25 and FY26 After Latest Q1
Piper Sandler Raises Canopy Growth Sales Estimates For FY25 and FY26 After Latest Q1
Aug 9, 2024
03:33 PM EDT, 08/09/2024 (MT Newswires) -- Piper Sandler noted Friday that Canopy Growth ( CGC ) reported Q1 Fiscal 2025 revenue and EBITDA below its estimates. Management reaffirmed its expectations to achieve positive adjusted EBITDA in the second half of FY25. Piper Sandler said while the first half of FY25 has minimal growth prospects, it models some improvement in...
Eli Lilly's Assurances on Key GLP-1 Drugs Should Ease Investor Concerns, UBS Says
Eli Lilly's Assurances on Key GLP-1 Drugs Should Ease Investor Concerns, UBS Says
Aug 9, 2024
03:37 PM EDT, 08/09/2024 (MT Newswires) -- Eli Lilly and Company's ( LLY ) forecasting-beating Q2 results showed key GLP-1 drugs Mounjaro and Zepbound benefiting from increased pricing and a better balance between supply and demand, UBS Securities said Thursday in a report. Investor concerns should ease with management confident that pricing will be stable and increasingly positive on production...
Buckle's Comparable Store Sales Drop in July Amid Footwear Weakness, UBS Says
Buckle's Comparable Store Sales Drop in July Amid Footwear Weakness, UBS Says
Aug 9, 2024
03:32 PM EDT, 08/09/2024 (MT Newswires) -- Buckle's (BKE) negative comparable store sales in July were likely due to certain issues within the company, including footwear declines, along with a softer retail environment, UBS said in a note emailed Friday. Comparable store sales in July fell 6.8% year over year, a deceleration from a decline of 5.7% in June, UBS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved